Cardiol Therapeutics Inc. (CRDL) vs Organigram Global Inc. (OGI)
- Cardiol Therapeutics Inc. CRDL 1.10 −4.35%
- Organigram Global Inc. OGI 0.93 0.00%
Cardiol Therapeutics Inc. and Organigram Global Inc. are both Drug Manufacturers Specialty & Generic companies. Cardiol Therapeutics Inc. and Organigram Global Inc. are of similar size ($138.8M and $131.4M). Cardiol Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Organigram Global Inc. trades at 2.0×. Organigram Global Inc. has the higher net margin (28.4% vs 0.00%) and the lower return on invested capital (−1.53% vs 0.00%). Across the 14 metrics below, Organigram Global Inc. leads on 8 and Cardiol Therapeutics Inc. on 6.
Valuation
Profitability
| Metric | CRDL | OGI | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 0.00% | 36.47% | 53.94% |
| Operating margin | 0.00% | (3.91%) | 0.00% |
| Net margin | 0.00% | 28.44% | 0.00% |
| Free cash flow margin | 0.00% | (9.46%) | 0.00% |
| Return on equity | (171.13%) | 20.20% | (0.40%) |
| Return on assets | (124.40%) | 12.70% | (3.32%) |
| Return on invested capital | 0.00% | (1.53%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack